China Products

All Natural EmphyClear OTC Nasal Spray (OTC, No prescription)

  • 2 Drug Patents filed
  • 3 Fully Approved China OTC Nasal Spray products that are being Manufactured by our strategic partner Pharmamax in China (China Medical Cities) and is available for the Chinese market and Asia, under the brand name BreatheMax 
  • Drug Free, Non-Steroidal Nasal Spray for Children/Adults that is clinically proven to immediately relieve congestion
  • Over 3 million units have been manufactured and distributed to 200+ China Hospitals (including the top Respiratory hospitals for children and several thousand Chinese Pharmacies)

All Natural EmphyClear COPD/Asthma Spray (Prescription)

  • 2 Drug Patents
  • Drug Free, Non-Steroidal COPD/Asthma Spray for Children/Adults that has been shown to help relieve Lung inflammation and improve Lung function in US Phase I/II Clinical Trials
  • Completed US Phase I and Phase II Clinical Trials for COPD/Asthma/Cystic Fibrosis/Interstitial Lung Disease
  • Received US FDA Orphan Drug Designation in 2005 for Cystic Fibrosis and Interstitial Lung Disease
  • Final China Clinical Trials have been conducted in China for three years and completion anticipated in 2018 

EMPHYCLEAR 70% LOWER STEROID nasal SPRAY (PRESCRIPTION)

  • 2 Drug Patents
  • Completed US Clinicals for a Patented 70% lower steroid version of a well known, off-patent Nasal Spray that meets the new US FDA safety requirement and got equal or better efficacy
  • US Final Clinical Trials are planned for 2019  

EmphyClear 70% Lower Steroid COPD/Asthma Spray (Prescription)

  • 2 Drug Patents
  • Completed US Clinicals for a Patented 70% lower steroid version of a well known, off-patent COPD/Asthma Spray that meets the new US FDA safety requirement and got equal or better efficacy
  • US Final Clinical Trials are planned for 2019 

With the exception of EmphyClear Nasal Spray (OTC), all other products (EmphyClear COPD, 70% Lower Steroid Nasal Spray and COPD Spray, Smoking Cessation Spray, Alzheimer's Spray) are Prescription Products that are still in the Clinical Trial Stage.

Note: (EmphyClear Asthma, EmphyClear Nasal Prescription, Alzheimer's Nasal Spray, and Smoking Cessation) are currently in the Clinical Trials stage and will be a Prescription product when available.